CN1411830A - Medicine for curing hypertension and its preparation method - Google Patents
Medicine for curing hypertension and its preparation method Download PDFInfo
- Publication number
- CN1411830A CN1411830A CN01128978A CN01128978A CN1411830A CN 1411830 A CN1411830 A CN 1411830A CN 01128978 A CN01128978 A CN 01128978A CN 01128978 A CN01128978 A CN 01128978A CN 1411830 A CN1411830 A CN 1411830A
- Authority
- CN
- China
- Prior art keywords
- radix
- crushed
- order fine
- medicine
- usefulness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 42
- 229940079593 drug Drugs 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title claims description 5
- 239000000843 powder Substances 0.000 claims description 31
- 238000011282 treatment Methods 0.000 claims description 22
- 230000001631 hypertensive effect Effects 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 12
- 241000208340 Araliaceae Species 0.000 claims description 9
- 241000255791 Bombyx Species 0.000 claims description 9
- 241000005787 Cistanche Species 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 9
- 241000237636 Pheretima Species 0.000 claims description 9
- 241000522620 Scorpio Species 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 239000009490 scorpio Substances 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 230000032696 parturition Effects 0.000 claims description 2
- 238000010791 quenching Methods 0.000 claims description 2
- 230000005070 ripening Effects 0.000 claims description 2
- 238000009738 saturating Methods 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 235000021419 vinegar Nutrition 0.000 claims description 2
- 239000000052 vinegar Substances 0.000 claims description 2
- 239000011805 ball Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 abstract description 6
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 10
- 206010019468 Hemiplegia Diseases 0.000 description 7
- 230000035487 diastolic blood pressure Effects 0.000 description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 6
- 229910052753 mercury Inorganic materials 0.000 description 6
- 230000035488 systolic blood pressure Effects 0.000 description 6
- 208000006011 Stroke Diseases 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 4
- 102000004895 Lipoproteins Human genes 0.000 description 4
- 108090001030 Lipoproteins Proteins 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000005541 ACE inhibitor Substances 0.000 description 2
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 2
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 108010071289 Factor XIII Proteins 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001523579 Ostrea Species 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 241001530126 Scrophularia Species 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine composition for curing hypertension. Said medicine is made up by using pure Chinese medicinal materials, and has the obvious therapeutic effect for curing angiocardiopathy, cerebrovascular disease, coronary heart disease and atherosis resulted from hypertension.
Description
The present invention relates to the hypertensive pharmaceutical composition of a kind of treatment, particularly a kind of is the hypertensive medicine of treatment that raw material is made with the animals and plants Chinese herbal medicine.
Hypertension is a kind of clinical common diseases, based on the syndrome of systemic arterial blood pressure rising.No matter can be divided into essential hypertension and secondary hypertension disease, be former or secondary, can both cause peripheral vessels, and the organic change of internal organs can cause the pathological changes of organs such as blood vessel, brain, the heart, kidney to cause coronary heart disease, heart failure etc.It is higher that hypertension causes human mortality rate, and according to statistics to 1997, hypertension accounts for 40% of China people death, so hypertension and caused cardiovascular and cerebrovascular disease thereof are human No.1 killers.
Hypertension will be treated throughout one's life, treats hypertensive medicine and not only will bring high blood pressure down, and will reduce the morbidity and the dead danger of cardiovascular and cerebrovascular disease, and in general, treatment hypertension mainly adopts Western medicine, but the Western medicine toxic side effect is big, and curative effect is single, and cure rate is low.Have some Chinese medicines to be used for the treatment of hypertension, but Chinese medicine prevention hypertension characteristic is not outstanding for many years, clinical actual effect is not high yet, and treatment means is single, so also do not obtain good effect.This is not that Chinese medicine can't be used for treating hypertension, but existing means fail from the viewpoint serious analysis pathogeny of motherland's medical science, thereby writes out a prescription medication targetedly.
The object of the present invention is to provide a kind of energy blood fat reducing, promote the internal body balance, and reduce, alleviate the treatment hypertension drug of the cardiovascular and cerebrovascular disease that causes by hypertension.
Another object of the present invention provides the preparation method of treatment hypertension drug.
Solution of the present invention is based on motherland's medical science to hypertensive understanding and Therapeutic Principle, be suitable for the compound recipe pharmacological property of Chinese medicine, adjust human body negative and positive, QI and blood, internal organs, meridians, cold and heat etc. are whole, it is long-pending that the utilization drug for invigorating blood circulation and eliminating stasis picks the stasis of blood of scraping meridians, it is unimpeded to improve the blood vessel meridians, the employing current meridian qi and blood of promoting the circulation of blood medicine of regulating the flow of vital energy, improve the four stages in the course of an epidemic febrile disease relation, the effective ingredient of utilization traditional Chinese medical science medicine, force the decomposition of lipoprotein in the blood, bring high blood pressure down, thus the cardiovascular and cerebrovascular disease of effectively treating hypertension and causing by hypertension.
Medicine of the present invention is made (consumption is a weight portion) by following component.
Radix Polygoni Multiflori 5-13 Rhizoma Chuanxiong 1-10 Radix Angelicae Sinensis 1-10 Bulbus Fritillariae Cirrhosae 1-10
Radix Rehmanniae 1-5 Flos Carthami 1-10 Bombyx Batryticatus 1-5 Radix Scrophulariae 1-10
Pericarpium Citri Reticulatae Viride 1-3 Concha Ostreae 1-10 Herba Taxilli 5-13 Radix Salviae Miltiorrhizae 5-13
Radix Et Rhizoma Rhei 1-3 Radix Ginseng 1-5 Radix Notoginseng 1-5 Scorpio 1-5
Herba Cistanches 1-5 Zaocys 1-5 Concha Haliotidis 1-5 Semen Cassiae 5-13
Radix Puerariae 1-10 Haematitum 1-5 Fructus Tribuli 1-5 Spica Prunellae 5-13
Caulis Spatholobi 1-10 Ramulus Uncariae Cum Uncis 5-13 Radix Astragali 5-13 Rhizoma Acori Graminei 1-5
Pheretima 1-10
The weight proportion scope of the formula optimization of medicine of the present invention is:
Radix Polygoni Multiflori 7-11 Rhizoma Chuanxiong 3-6 Radix Angelicae Sinensis 3-6 Bulbus Fritillariae Cirrhosae 3-6
Radix Rehmanniae 1-2 Flos Carthami 3-6 Bombyx Batryticatus 1-3 Radix Scrophulariae 3-6
Pericarpium Citri Reticulatae Viride 1-2 Concha Ostreae 3-6 Herba Taxilli 7-11 Radix Salviae Miltiorrhizae 7-11
Radix Et Rhizoma Rhei 1-2 Radix Ginseng 1-3 Radix Notoginseng 1-3 Scorpio 1-3
Herba Cistanches 1-3 Zaocys 1-3 Concha Haliotidis 1-3 Semen Cassiae 7-11
Radix Puerariae 7-11 Haematitum 1-3 Fructus Tribuli 1-3 Spica Prunellae 7-11
Caulis Spatholobi 3-6 Ramulus Uncariae Cum Uncis 7-11 Radix Astragali 7-11 Rhizoma Acori Graminei 1-3
Pheretima 3-6
Optimum weight part proportioning of medicine of the present invention is:
Radix Polygoni Multiflori 7 Rhizoma Chuanxiongs 3 Radix Angelicae Sinensis 3 Bulbus Fritillariae Cirrhosaes 3
The Radix Rehmanniae 1 Flos Carthami 3 Bombyx Batryticatus 1 Radix Scrophulariae 3
Pericarpium Citri Reticulatae Viride 1 Concha Ostreae 3 Herba Taxillis 7 Radix Salviae Miltiorrhizaes 7
Radix Et Rhizoma Rhei 1 Radix Ginseng 1 Radix Notoginseng 1 Scorpio 1
Herba Cistanches 1 Zaocys 1 Concha Haliotidis 1 Semen Cassiae 7
Radix Puerariae 7 Haematitums 1 Fructus Tribuli 1 Spica Prunellae 7
Caulis Spatholobi 3 Ramulus Uncariae Cum Uncis 7 Radixs Astragali 7 Rhizoma Acori Gramineis 1
Pheretima 3
The method of above-mentioned each component being made medicine of the present invention is:
1, it is an amount of black saturating with boiling Radix Polygoni Multiflori to be added water with Semen sojae atricolor, drying and crushing to 120 order fine powder;
2, with Rhizoma Chuanxiong drying and crushing to 120 order fine powder;
3, Radix Angelicae Sinensis is added loess and fry usefulness, drying and crushing to 120 order fine powder;
4, with giving birth to usefulness after the Bulbus Fritillariae Uninbracteatae drying, be crushed to 120 order fine powders;
5, Bombyx Batryticatus and Testa Tritici are fried together, be crushed to thin part of 120 orders;
6, vinegar is gone up in the Pericarpium Citri Reticulatae Viride section and fried usefulness, be crushed to 120 order fine powders;
7, the Radix Et Rhizoma Rhei section is fried usefulness with wine, be crushed to 120 order fine powders;
8, Radix Ginseng is given birth to usefulness after concocting, and is crushed to 120 order fine powders;
9, Scorpio is concocted the back and give birth to usefulness, be crushed to 120 order fine powders;
10, Herba Cistanches is added yellow wine and steam thoroughly crushed after being dried to 120 order fine powder;
11, Zaocys is decaptitated add the stewing back of yellow wine and fry usefulness, be crushed to 120 order fine powders;
12, Haematitum is smashed to pieces fire and forged and quench, be crushed to 120 order fine powders;
13, Fructus Tribuli is added saline and fry usefulness, be crushed to 120 order fine powders;
14, will fry smelling removal behind the Pheretima steeping in wine, be crushed to 120 order fine powders;
15, Flos Carthami, Radix Scrophulariae, Concha Ostreae, Herba Taxilli, Radix Salviae Miltiorrhizae, Radix Notoginseng, Concha Haliotidis, Semen Cassiae, Radix Puerariae, Spica Prunellae, Caulis Spatholobi, Ramulus Uncariae Cum Uncis, the Radix Astragali, Rhizoma Acori Graminei etc. are given birth to usefulness, crushed after being dried to 120 order fine powder;
16, with above-mentioned whole medicament components by after the described mixed, carry out ripening at 100-110 ℃, sterilization treatment 10-30 minute, get final product the hypertensive powder medicine of treatment.
Powder after the maturation process can be made cream, ball, loose or capsule, to meet patient's the custom of taking by the conventional treatment method of Chinese medicine.
Medicament of the present invention contains the various active ingredients that human body is played an important role, and its effect concludes to get up roughly to have:
1, medicament of the present invention has stronger blood pressure lowering, blood fat reducing, diuretic, kalium replenishment, synergism such as replenish the calcium.By drug influence power, in diuretic and increase the absorption of potassium, potassium, sugar, calcium, water, electrolyte metabolism are had no adverse effects.Brain, the heart, kidney, target organ there is protective effect, reversing left ventricular hypertrophy, the incidence rate of minimizing apoplexy, coronary heart disease.
2, effects such as stronger blood circulation promoting and blood stasis dispelling, dredge the meridian passage, heat reliving and toxin-eliminating, clearing away phlegm lead to surreptitiously, refreshment are arranged, can improve the blood vessel microcirculation, reduce fibrin stabilizing factor and improve blood inner fibrin lytic activity, shorten the dissolution time of euglobulin, reduce surface activity of blood platelet and aggregation, blood viscosity lowering falls tampon and forms.To feritin--hypertensin system (RAS) can be regulated water-electrolyte metabolism in vivo, antiotasis and sympathetic nervous system activity, by suppressing the effect of angiotensin converting enzyme inhibitor (ACEI), produce stronger blood pressure lowering performance, reverse blood vessel wall and the bad of heart and reinvent, recover 26S Proteasome Structure and Function.
3, the characteristic of the compound recipe pharmacology of utilization Chinese herbal medicine influences the transhipment of calcium ion, makes smooth muscle loose, and expansion small artery and vein blood vessel reduce vascular resistance, increase brain, heart coronary flow, prevent the myocardial ischemia necrosis.
4, animal and plant class medicine is regulated equilibrium between yin and yang after acting on human body, homoiostasis, and it is longer to keep effective drug duration, and blood pressure lowering is lasting, protection cardiorenal function, slow down aging.
Medicament of the present invention particularly has the obvious treatment effect to following disease in view of above-mentioned functions is arranged:
1, hypertensive patients left ventricular hypertrophy, patients with coronary heart disease;
2, hypertensive patients nephropathy, urine protein 24 hours 〉=1 gram person;
3, hypertension complicated with diabetes mellitus or impaired glucose tolerance and have insulin to hang down anti-person;
4, hypertensive patients atherosclerosis, the unusual person of cardiovascular and cerebrovascular vessel;
5, hypertensive patients bronchus and pulmonary disease person.
For showing the effect of hypertension therapy of the present invention, specially make more careful clinical statistics.Select typical hyperpietic's 100 examples, wherein male 64 examples, women 36 examples, the age minimum be 40 years old, maximum is 87 years old, blood pressure soprano systolic pressure 240 millimetress of mercury, diastolic pressure 140 millimetress of mercury, minimum systolic pressure 190 millimetress of mercury, diastolic pressure 100 millimetress of mercury, the lipoprotein index all has in various degree and increases in the blood samples of patients, and left ventricle is plump in various degree, wherein hypertension stroke hemiplegia patient 48 examples.
Above-mentioned object of statistics is after taking medicament of the present invention, and what medicine time was the longest is 14 months, the shortest 3 months, following up a case by regular visits to after the healing of taking medicine, blood pressure remains on systolic pressure 140 millimetress of mercury always, and below diastolic pressure 90 millimetress of mercury, the lipoprotein index is all in normal range in the blood.Recurrence patient 4 examples, treatment rate reaches 96%.
Now enumerate the curative effect of some indivedual case explanations medicine of the present invention again.
Case 1: bright certain, man, 76 years old now, South Sichuan people from county, patient fall down to the ground suddenly in July, 84 and faint the left side hemiplegia, be diagnosed as cerebral thrombosis through the locality, treatment is invalid after half a year, comes the inventor to locate to seek medical advice, hemiplegia on inspection, the walking of can not standing, dysphonia, blood pressure systolic pressure 210mmHg, diastolic pressure 110mmHg, TV x-ray fluoroscopy left ventricular hypertrophy, the blood lipoprotein is not looked into because of the unconditional inspection of hospital, diagnosis hypertension stroke hemiplegia, coronary heart disease, be in take medicament of the present invention after, the walking of leaving the bed voluntarily in 2 months, blood pressure is normal, and walking is normal substantially after taking medicine four months, competent slight housework was taken medicine 8 months altogether after 6 months.Followed up a case by regular visits to the patient 15 years, patient's blood pressure remains at systolic pressure 120mmHg, and diastolic pressure 70mmHg can participate in any physical work.
Case 2: Lee, man, 65 years old now, the patient fell down to the ground suddenly in February, 94, was diagnosed the left side hemiplegia after 4 hours by the inventor, can not sit up, rapid breathing, pulse is strong greatly, 38 ℃ of body temperature, dysphonia, blood pressure: systolic pressure 220mmHg, diastolic pressure 115mmHg, TV X perspective: left ventricular hypertrophy is diagnosed as hypertension apoplexy hemiplegia, coronary heart disease, after rescuing a week, take medicine of the present invention with Western medicine, two weeks held up down and turn walking, and three weeks were walked out hospital, went home to take medicine, the county hospital check is gone in drug withdrawal after February, change clothes Western medicine February, stroke hemiplegia recurrence for the second time after three months, secondary is sent the diagnosis and treatment by the inventor here, clinical state and last time are basic identical on inspection, after go home to take medicament of the present invention continuously 10 months, followed up a case by regular visits to 8 years, blood pressure is normal substantially, the fat disappearance now can normally be done some housework.
More than the above case, too numerous to enumerate.
Embodiment:
Take by weighing material by following proportioning:
4 kilograms of 4 kilograms of Bulbus Fritillariae Cirrhosaes of 4 kilograms of Radix Angelicae Sinensis of 8 kilograms of Rhizoma Chuanxiongs of Radix Polygoni Multiflori
4 kilograms of 2 kilograms of Radix Scrophulariaes of 4 kilograms of Bombyx Batryticatus of 1.2 kilograms of Flos Carthamis of the Radix Rehmanniae
8 kilograms of 8 kilograms of Radix Salviae Miltiorrhizaes of 4 kilograms of Herba Taxillis of 1.2 kilograms of Concha Ostreaes of Pericarpium Citri Reticulatae Viride
2 kilograms of 2 kilograms of Scorpios of 2 kilograms of Radix Notoginseng of 1.2 kilograms of Radix Ginsengs of Radix Et Rhizoma Rhei
8 kilograms of 2 kilograms of Semen Cassiaes of 2 kilograms of Concha Haliotidis of 2 kilograms of Zaocyss of Herba Cistanches
8 kilograms of 2 kilograms of Spica Prunellaes of 2 kilograms of Fructus Tribulis of 8 kilograms of Haematitums of Radix Puerariae
2 kilograms of 8 kilograms of Rhizoma Acori Gramineis of 8 kilograms of Radixs Astragali of 4 kilograms of Ramulus Uncariae Cum Uncis of Caulis Spatholobi
4 kilograms of Pheretimas
Claims (7)
1, the hypertensive medicine of a kind of treatment, it is characterized in that: it is the medicament of being made by the following weight proportioning: Radix Polygoni Multiflori 5-13 Rhizoma Chuanxiong 1-10 Radix Angelicae Sinensis 1-10
Bulbus Fritillariae Cirrhosae 1-10
Radix Rehmanniae 1-5 Flos Carthami 1-10 Bombyx Batryticatus 1-5 Radix Scrophulariae 1-10
Pericarpium Citri Reticulatae Viride 1-3 Concha Ostreae 1-10 Herba Taxilli 5-13 Radix Salviae Miltiorrhizae 5-13
Radix Et Rhizoma Rhei 1-3 Radix Ginseng 1-5 Radix Notoginseng 1-5 Scorpio 1-5
Herba Cistanches 1-5 Zaocys 1-5 Concha Haliotidis 1-5 Semen Cassiae 5-13
Radix Puerariae 1-10 Haematitum 1-5 Fructus Tribuli 1-5 Spica Prunellae 5-13
Caulis Spatholobi 1-10 Ramulus Uncariae Cum Uncis 5-13 Radix Astragali 5-13 Rhizoma Acori Graminei 1-5
Pheretima 1-10
2, the hypertensive medicine of treatment according to claim 1, it is characterized in that: the weight proportion of medicine of the present invention is:
Radix Polygoni Multiflori 7-11 Rhizoma Chuanxiong 3-6 Radix Angelicae Sinensis 3-6 Bulbus Fritillariae Cirrhosae 3-6
Radix Rehmanniae 1-2 Flos Carthami 3-6 Bombyx Batryticatus 1-3 Radix Scrophulariae 3-6
Pericarpium Citri Reticulatae Viride 1-2 Concha Ostreae 3-6 Herba Taxilli 7-11 Radix Salviae Miltiorrhizae 7-11
Radix Et Rhizoma Rhei 1-2 Radix Ginseng 1-3 Radix Notoginseng 1-3 Scorpio 1-3
Herba Cistanches 1-3 Zaocys 1-3 Semen Cassiae 1-3 Semen Cassiae 7-11
Radix Puerariae 7-11 Haematitum 1-3 Fructus Tribuli 1-3 Spica Prunellae 7-11
Caulis Spatholobi 3-6 Ramulus Uncariae Cum Uncis 7-11 Radix Astragali 7-11 Rhizoma Acori Graminei 1-3
Pheretima 3-6
3, the hypertensive medicine of treatment according to claim 1 is characterized in that: the weight portion proportioning of medicine of the present invention is:
Radix Polygoni Multiflori 7 Rhizoma Chuanxiongs 3 Radix Angelicae Sinensis 3 Bulbus Fritillariae Cirrhosaes 3
The Radix Rehmanniae 1 Flos Carthami 3 Bombyx Batryticatus 1 Radix Scrophulariae 3
Pericarpium Citri Reticulatae Viride 1 Concha Ostreae 3 Herba Taxillis 7 Radix Salviae Miltiorrhizaes 7
Radix Et Rhizoma Rhei 1 Radix Ginseng 1 Radix Notoginseng 1 Scorpio 1
Herba Cistanches 1 Zaocys 1 Concha Haliotidis 1 Semen Cassiae 7
Radix Puerariae 7 Haematitums 1 Fructus Tribuli 1 Spica Prunellae 7
Caulis Spatholobi 3 Ramulus Uncariae Cum Uncis 7 Radixs Astragali 7 Rhizoma Acori Gramineis 1
Pheretima 3
4, according to claim 1, the hypertensive medicine of 2 or 3 described treatments, it is characterized in that: said medicament is a said dosage form on any pharmaceutics.
5, the hypertensive medicine of treatment according to claim 4 is characterized in that: said medicament is cream, pellet, ball, looses or capsule.
6, a kind of preparation method for the treatment of hypertension drug is characterized in that:
(1) it is an amount of black saturating with boiling Radix Polygoni Multiflori to be added water with Semen sojae atricolor, drying and crushing to 120 order fine powder;
(2) with Rhizoma Chuanxiong drying and crushing to 120 order fine powder;
(3) Radix Angelicae Sinensis is added loess and fry usefulness, drying and crushing to 120 order fine powder;
(4) with giving birth to usefulness after the Bulbus Fritillariae Uninbracteatae drying, be crushed to 120 order fine powders;
(5) Bombyx Batryticatus and Testa Tritici are fried together, be crushed to thin part of 120 orders;
(6) usefulness is given birth in the Pericarpium Citri Reticulatae Viride section, be crushed to 120 order fine powders;
(7) the Radix Et Rhizoma Rhei section is fried usefulness with wine, be crushed to 120 order fine powders;
(8) Radix Ginseng is given birth to usefulness after concocting, and is crushed to 120 order fine powders;
(9) Scorpio is concocted the back and give birth to usefulness, be crushed to 120 order fine powders;
(10) Herba Cistanches is added yellow wine and steam thoroughly crushed after being dried to 120 order fine powder;
(11) Zaocys is decaptitated add yellow wine and dry after stewing, be crushed to 120 order fine powders;
(12) Haematitum is smashed to pieces fiery quench in vinegar, be crushed to 120 order fine powders;
(13) Fructus Tribuli is added saline and fry usefulness, be crushed to 120 order fine powders;
(14) will fry smelling removal behind the Pheretima steeping in wine, be crushed to 120 order fine powders;
(15) Flos Carthami, Radix Scrophulariae, Concha Ostreae, Herba Taxilli, Radix Salviae Miltiorrhizae, Radix Notoginseng, Concha Haliotidis, Semen Cassiae, Radix Puerariae, Spica Prunellae, Caulis Spatholobi, Ramulus Uncariae Cum Uncis, the Radix Astragali, Rhizoma Acori Graminei etc. are given birth to usefulness, crushed after being dried to 120 order fine powder;
7, the preparation method of hypertension drug according to claim 6 is characterized in that: above-mentioned whole medicament components by after the described mixed, are carried out ripening at 100-110 ℃, sterilization treatment 10-30 minute, get final product the hypertensive powder medicine of treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011289783A CN1240416C (en) | 2001-10-17 | 2001-10-17 | Medicine for curing hypertension and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011289783A CN1240416C (en) | 2001-10-17 | 2001-10-17 | Medicine for curing hypertension and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1411830A true CN1411830A (en) | 2003-04-23 |
| CN1240416C CN1240416C (en) | 2006-02-08 |
Family
ID=4668786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011289783A Expired - Fee Related CN1240416C (en) | 2001-10-17 | 2001-10-17 | Medicine for curing hypertension and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1240416C (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1296080C (en) * | 2004-12-21 | 2007-01-24 | 贾洪章 | Liver clearing blood pressure lowering capsule nd its preparation method |
| CN1298340C (en) * | 2004-10-29 | 2007-02-07 | 南京生物工程与医药科技发展有限公司 | Chinese traditional medicine composition for treating blood stasis qi-stagnation type cardiodynia and preparation method thereof |
| CN101264189B (en) * | 2008-05-05 | 2010-06-16 | 胡建新 | Cardiac disease rehabilitation proprietary Chinese medicine |
| CN101024002B (en) * | 2007-03-29 | 2010-08-11 | 牟善芳 | Oral Chinese medicine composition for treating hypertension |
| CN101554434B (en) * | 2008-04-09 | 2011-02-09 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating clinical hypertension |
| CN101167876B (en) * | 2007-11-09 | 2011-04-06 | 北京中科雍和医药技术有限公司 | Medicinal composition for treating high blood pressure and its complication and preparation method thereof |
| CN102091291A (en) * | 2010-12-06 | 2011-06-15 | 济南金鼎信息技术有限公司 | Chinese medicine composition for treating cerebral arteriosclerosis |
| CN102151326A (en) * | 2011-04-18 | 2011-08-17 | 苑学 | Combined Chinese medicine for curing hypertension and hyperlipaemia |
| CN101027072B (en) * | 2004-08-27 | 2011-09-28 | 顺天生物科技股份有限公司 | Herbal pharmaceutical compositions for prophylaxis and/or treatment of cardiovascular diseases and the method of preparing the same |
| CN101422241B (en) * | 2008-12-10 | 2011-12-21 | 许宗磊 | Antihypertensive health-care porridge |
| CN102727762A (en) * | 2012-07-16 | 2012-10-17 | 中国药科大学 | Related ingredient combination with function of relaxing vessels in traditional Chinese medicine for reducing blood pressure |
| CN102784273A (en) * | 2012-08-01 | 2012-11-21 | 王淑芳 | Method for preparing traditional Chinese medicine for treating insomnia caused by high blood pressure |
| CN102920899A (en) * | 2012-10-23 | 2013-02-13 | 四川元安药业有限公司 | Medicine for treating coronary heart diseases and preparation method thereof |
| CN103041361A (en) * | 2013-01-17 | 2013-04-17 | 广西东兴市创新特色医药科技发展有限公司 | Medicament for treating three-high disease (high cholesterol, high blood pressure, high blood sugar) and preparation method thereof |
| CN103301270A (en) * | 2013-07-08 | 2013-09-18 | 陈明 | Medicine for preventing and treating coronary heart disease and preparation method thereof |
| CN106421564A (en) * | 2016-12-09 | 2017-02-22 | 李建才 | Traditional Chinese medicine for treating essential hypertension |
| CN111588832A (en) * | 2020-07-09 | 2020-08-28 | 文秋方 | Herbal purification liquid |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614279A (en) * | 2012-04-20 | 2012-08-01 | 北京绿源求证科技发展有限责任公司 | Chinese medicine for treating diabetic hypertension |
-
2001
- 2001-10-17 CN CNB011289783A patent/CN1240416C/en not_active Expired - Fee Related
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101027072B (en) * | 2004-08-27 | 2011-09-28 | 顺天生物科技股份有限公司 | Herbal pharmaceutical compositions for prophylaxis and/or treatment of cardiovascular diseases and the method of preparing the same |
| CN1298340C (en) * | 2004-10-29 | 2007-02-07 | 南京生物工程与医药科技发展有限公司 | Chinese traditional medicine composition for treating blood stasis qi-stagnation type cardiodynia and preparation method thereof |
| CN1296080C (en) * | 2004-12-21 | 2007-01-24 | 贾洪章 | Liver clearing blood pressure lowering capsule nd its preparation method |
| CN101024002B (en) * | 2007-03-29 | 2010-08-11 | 牟善芳 | Oral Chinese medicine composition for treating hypertension |
| CN101167876B (en) * | 2007-11-09 | 2011-04-06 | 北京中科雍和医药技术有限公司 | Medicinal composition for treating high blood pressure and its complication and preparation method thereof |
| CN101554434B (en) * | 2008-04-09 | 2011-02-09 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating clinical hypertension |
| CN101264189B (en) * | 2008-05-05 | 2010-06-16 | 胡建新 | Cardiac disease rehabilitation proprietary Chinese medicine |
| CN101422241B (en) * | 2008-12-10 | 2011-12-21 | 许宗磊 | Antihypertensive health-care porridge |
| CN102091291B (en) * | 2010-12-06 | 2012-05-09 | 李新焕 | Traditional Chinese medicine composition for treating cerebral arteriosclerosis |
| CN102091291A (en) * | 2010-12-06 | 2011-06-15 | 济南金鼎信息技术有限公司 | Chinese medicine composition for treating cerebral arteriosclerosis |
| CN102151326A (en) * | 2011-04-18 | 2011-08-17 | 苑学 | Combined Chinese medicine for curing hypertension and hyperlipaemia |
| CN102151326B (en) * | 2011-04-18 | 2012-07-18 | 苑学 | Chinese medicine composition for curing hypertension and hyperlipaemia |
| CN102727762A (en) * | 2012-07-16 | 2012-10-17 | 中国药科大学 | Related ingredient combination with function of relaxing vessels in traditional Chinese medicine for reducing blood pressure |
| CN102784273A (en) * | 2012-08-01 | 2012-11-21 | 王淑芳 | Method for preparing traditional Chinese medicine for treating insomnia caused by high blood pressure |
| CN102920899A (en) * | 2012-10-23 | 2013-02-13 | 四川元安药业有限公司 | Medicine for treating coronary heart diseases and preparation method thereof |
| CN102920899B (en) * | 2012-10-23 | 2014-03-26 | 四川元安药业有限公司 | Medicine for treating coronary heart diseases and preparation method thereof |
| CN103041361A (en) * | 2013-01-17 | 2013-04-17 | 广西东兴市创新特色医药科技发展有限公司 | Medicament for treating three-high disease (high cholesterol, high blood pressure, high blood sugar) and preparation method thereof |
| CN103041361B (en) * | 2013-01-17 | 2014-04-30 | 广西东兴市创新特色医药科技发展有限公司 | Medicament for treating three-high disease (high cholesterol, high blood pressure, high blood sugar) and preparation method thereof |
| CN103301270A (en) * | 2013-07-08 | 2013-09-18 | 陈明 | Medicine for preventing and treating coronary heart disease and preparation method thereof |
| CN106421564A (en) * | 2016-12-09 | 2017-02-22 | 李建才 | Traditional Chinese medicine for treating essential hypertension |
| CN111588832A (en) * | 2020-07-09 | 2020-08-28 | 文秋方 | Herbal purification liquid |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1240416C (en) | 2006-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
| CN100546644C (en) | A kind of external Chinese medicinal liquid for treating wind-cold-damp neck, shoulder, waist and leg pain | |
| CN102293947A (en) | Traditional Chinese medicine for treating hypertension | |
| CN101168042A (en) | Traditional Chinese medicine preparation for curing cardiovascular and cerebrovascular diseases and preparing method | |
| CN1650923A (en) | Medicinal composition for treating theumalism and rheumatism diseases | |
| CN100388932C (en) | Method for preparing externally applied medicine for feet tinea | |
| CN1628760A (en) | Traditional Chinese medicinal formulation for treating cardiovascular and cerebrovascular disease | |
| CN101537060B (en) | Medicine for treating AIDS | |
| CN105056124A (en) | Medicine for treating hypertension and diabetes | |
| CN1803187A (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN101822789B (en) | Hypotensor treating essential hypertension | |
| CN104758743A (en) | Traditional Chinese medicine foot fumigating powder for treating rheumatism as well as preparation method and using method thereof | |
| CN1184989C (en) | Weight-reducing Chinese medicine acted on acupoint | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1562116A (en) | Chinese medicine preparation with invigorating kidney function | |
| CN1086586C (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
| CN1733242A (en) | A kind of medicine for treating qi deficiency and blood stasis type chest obstruction (coronary heart disease) and its preparation process | |
| CN1132603C (en) | Compound Wuduqing capsule of blister beetle | |
| CN103638428A (en) | Traditional Chinese medicinal composition for treating coronary heart disease | |
| CN101869660B (en) | Capsules for Chronic Fatigue Syndrome and Menopausal Syndrome | |
| CN103655917B (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease | |
| CN1088801A (en) | Chinese patent medicine Jinguanpian tablets and the method for making thereof of treatment insensitive impediment, particularly RA and AS | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN105963582A (en) | Traditional Chinese medicine preparation for treating diabetes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060208 Termination date: 20101017 |